Response of a 4 weeks treatment with daily once 320 µg ciclesonide on airway
hyperresponsiveness assessed with mannitol.
Hypothesis: Treatment with inhaled ciclesonide reduces airway hyper-responsiveness in 80% of
hyper-responsive patients compared to 20% only in the placebo group and the group without
airway hyper-responsiveness.